AMENDMENT TO CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • August 9th, 2024 • BioCardia, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 9th, 2024 Company IndustryThis Amendment to the Change in Control and Severance Agreement (the “Amendment”) is entered into by and between BioCardia, Inc. (the “Company”) and Peter Altman (“Executive”) (together, the “Parties,” or individually, a “Party”).